Company profilePharmaceutical#553 of 1,318 in Pakistan✓ No DRAP alerts

Himedic Pharmaceuticals Pvt Ltd

Pharmaceutical company · 23 brands · 20 molecules

23 registered products 25 pharmaceutical brands 20 distinct molecules 0 DRAP alerts

Company overview

23
registered products
25
pharmaceutical brands
20
distinct molecules
0
therapeutic classes
0
DRAP alerts

Himedic Pharmaceuticals Pvt Ltd is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 23 product registrations across 20 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Himedic

22 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

22
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202522

Top molecules by brand count

Cefixime4 brands
Cephalexin4 brands
Cefixime ...... 200 Mg2 brands
Cefixime ...... 100 Mg1 brand
Ceftriaxone ...... 1.0 Gm1 brand
Ceftriaxone ...... 1 Gm1 brand
Ceftriaxone ...... 250 Mg1 brand
Ceftriaxone ...... 500 Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official35 products · Rs 81.67 – Rs 591.59
Median across source: Rs 262.82

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.11 shared molecules
ADVANCED PHARMACEUTICALS11 shared molecules
FRIENDS PHARMA (PVT) LTD11 shared molecules
NEXUS PHARMA (PVT) LTD10 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SAFE PHARMACEUTICAL (PVT) LTD. holds 54 molecules not in this portfolio
AcyclovirAdernaline 1MgAdrenalineAdrenaline InjAmikacinAmodiaquine
BIO LABS (PVT) LTD. holds 135 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
Arreta Pharmaceuticals (Pvt.) Ltd. holds 33 molecules not in this portfolio
ArtemetherAzithromycinCaffeineCeftazidime PentahydrateCefuroximeCefuroxime Axetil

Get the full profile for Himedic

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.